Avalo Therapeutics (AVTX) CSO Sells $52,012 in Company Stock

Jennifer Riley, the Chief Scientific Officer of Avalo Therapeutics (AVTX), sold $52,012 worth of stock in the company. The transaction involved a considerable amount of shares, which may reflect internal confidence or concerns within the company. Insider selling events like this can be closely monitored by investors, as they can influence market sentiment. This sale comes at a time when institutional interest in Avalo remains significant, so understanding such movements can impact investor perceptions and decision-making.